GoodRx Holdings Inc GDRX

NAS: GDRX | ISIN: US38246G1085   20/05/2024
7,130 USD (-4,68%)
(-4,68%)   20/05/2024
Grafiek GoodRx Holdings Inc Grafiek GoodRx Holdings Inc

GoodRx Holdings Inc in het nieuws

16 mei 2024 · GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

15 mei 2024 · GoodRx Holdings, Inc. Class Action: Levi & Korsinsky Reminds GoodRx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX · Persbericht

14 mei 2024 · GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit · Persbericht

13 mei 2024 · Levi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming Deadline · Persbericht

11 mei 2024 · GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

8 mei 2024 · GoodRx Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights - GDRX · Persbericht

6 mei 2024 · Lost Money on GoodRx Holdings, Inc.(GDRX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

3 mei 2024 · GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

26 april 2024 · GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

12 juli 2023 · CVS Caremark and GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members · Persbericht

Profiel GoodRx Holdings Inc

Internet Software/Diensten
Technologische diensten

Website: goodrx.com

Hoofdzetel: Santa Monica, CA vlag Verenigde Staten

CEO: Doug Hirsch

Werknemers: 893

Aandelen GoodRx Holdings Inc

Beurswaarde: 705,63 miljoen USD

Effecten: 94,34 miljoen

Winst per aandeel (12 maand):  PLUS

Beta: 2,17

Mijn selecties